Literature for inhibitor I04.003: kallistatin

(Topics flags: A Assay, T Target, K Knockout, E Expression, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

2022
1. Wang,Y., Chen,X.Y., Shang,K., Xu,Q., Li,Y.X., Du,Y. and Zhuan,L.
   [Relationship of the kallistatin gene expression with male spermatogenic dysfunction and its possible mechanism]
   Zhonghua Nan Ke Xue28, 976-984. PubMed  Europe PubMed
2021
2. Mao,Y., Qiao,J.D., Chen,S., Zhou,X., Wang,Z., Cai,S., Li,L. and Luo,Y.
   Kallistatin Inhibits Anoikis Resistance and Metastasis of Ectopic Endometrium Cells by Modulating MnSOD and Caspase 3 Signaling
   Reprod Sci PubMed  Europe PubMed DOI
3. Shashidhar,K.N., Lakshmaiah,V., Muninarayana,C. and Nallagangula,K.S.
   Quantitative ELISA for SERPINA4/kallistatin
   Biotechniques PubMed  Europe PubMed DOI
2020
4. Pamukcu,O., Ay,D., Uzum,K., Barlakketi,D., Kose,M., Baykan,A., Sunkak,S. and Narin,N.
   Role of kallistatin in pediatric patients with pulmonary arterial hypertension
   Turk J Pediatr62, 405-410. PubMed  Europe PubMed DOI
5. Zhuan,L., Shang,K., Guan,J., Li,Y.X., Mai,X.C. and Xu,Q.
   [Expression of the kallistatin gene in rat corpus cavernosum]
   Zhonghua Nan Ke Xue26, 223-227. PubMed  Europe PubMed
2019
6. Wu,H., Li,R., Zhang,Z., Jiang,H., Ma,H., Yuan,C., Sun,C., Li,Y. and Kong,B.
   Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
   J Ovarian Res12, 125-125. PubMed  Europe PubMed DOI  T
2018
7. Fruhbeck,G., Gomez-Ambrosi,J., Rodriguez,A., Ramirez,B., Valenti,V., Moncada,R., Becerril,S., Unamuno,X., Silva,C., Salvador,J. and Catalan,V.
   Novel protective role of kallistatin in obesity by limiting adipose tissue low grade inflammation and oxidative stress
   Metabolism87, 123-135. PubMed  Europe PubMed DOI
2017
8. Chao,J., Li,P. and Chao,L.
   Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress
   Biol Chem398, 1309-1317. PubMed  Europe PubMed DOI  V
9. McBride,J.D., Liu,X., Berry,W.L., Janknecht,R., Cheng,R., Zhou,K., Badiavas,E.V. and Ma,J.X.
   Transgenic expression of a canonical Wnt inhibitor, kallistatin, is associated with decreased circulating CD19(+) B lymphocytes in the peripheral blood
   Int J Hematol105, 748-757. PubMed  Europe PubMed DOI
2015
10. Lin,F., Zhou,A. and Wei,Z.
    Crystallization and crystallographic studies of kallistatin
    Acta Crystallogr F Struct Biol Commun71, 1135-1138. PubMed  Europe PubMed DOI  E
2013
11. Liu,X., Zhang,B., McBride,J.D., Zhou,K., Lee,K., Zhou,Y., Liu,Z. and Ma,J.X.
    Antiangiogenic and antineuroinflammatory effects of kallistatin through interactions with the canonical Wnt pathway
    Diabetes62, 4228-4238. PubMed  Europe PubMed DOI  K
2010
12. Jenkins,A.J., McBride,J.D., Januszewski,A.S., Karschimkus,C.S., Zhang,B., O'Neal,D.N., Nelson,C.L., Chung,J.S., Harper,C.A., Lyons,T.J. and Ma,J.X.
    Increased serum kallistatin levels in type 1 diabetes patients with vascular complications
    J Angiogenes Res2, 19-19. PubMed  Europe PubMed DOI
2006
13. Luo,L.Y. and Jiang,W.
    Inhibition profiles of human tissue kallikreins by serine protease inhibitors
    Biol Chem387, 813-816. PubMed  Europe PubMed DOI
2003
14. Miao,R.Q., Chen,V., Chao,L. and Chao,J.
    Structural elements of kallistatin required for inhibition of angiogenesis
    Am J Physiol Cell Physiol284, C1604-C1613. PubMed  Europe PubMed DOI
15. [YEAR:1-5-2003]Pimenta,D.C., Fogaca,S.E., Melo,R.L., Juliano,L. and Juliano,M.A.
    Specificity of S'1 and S'2 subsites of human tissue kallikrein using the reactive-centre loop of kallistatin: the importance of P'1 and P'2 positions in design of inhibitors
    Biochem J371, 1021-1025. PubMed  Europe PubMed DOI
2001
16. Chao,J., Miao,R.Q., Chen,V., Chen,L.M. and Chao,L.
    Novel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodeling
    Biol Chem382, 15-21. PubMed  Europe PubMed DOI
17. [YEAR:12-1-2001]Chen,V.C., Chao,L., Pimenta,D.C., Bledsoe,G., Juliano,L. and Chao,J.
    Identification of a major heparin-binding site in kallistatin
    J Biol Chem276, 1276-1284. PubMed  Europe PubMed DOI
18. [YEAR:12-1-2001]Pimenta,D.C., Oliveira,A., Juliano,M.A. and Juliano,L.
    Substrate specificity of human cathepsin D using internally quenched fluorescent peptides derived from reactive site loop of kallistatin
    Biochim Biophys Acta1544, 113-122. PubMed  Europe PubMed DOI  A
2000
19. [YEAR:8-12-2000]Chen,V.C., Chao,L. and Chao,J.
    Roles of the P1, P2, and P3 residues in determining inhibitory specificity of kallistatin toward human tissue kallikrein
    J Biol Chem275, 38457-38466. PubMed  Europe PubMed DOI
20. [YEAR:15-6-2000]Chen,V.C., Chao,L. and Chao,J.
    Reactive-site specificity of human kallistatin toward tissue kallikrein probed by site-directed mutagenesis
    Biochim Biophys Acta1479, 237-246. PubMed  Europe PubMed DOI
21. [YEAR:22-12-2000]Chen,V.C., Chao,L. and Chao,J.
    A positively charged loop on the surface of kallistatin functions to enhance tissue kallikrein inhibition by acting as a secondary binding site for kallikrein
    J Biol Chem275, 40371-40377. PubMed  Europe PubMed DOI
22. Pimenta,D.C., Chen,V.C., Chao,J., Juliano,M.A. and Juliano,L.
    Alpha1-antichymotrypsin and kallistatin hydrolysis by human cathepsin D
    J Protein Chem19, 411-418. PubMed  Europe PubMed DOI
1995
23. Chao,J. and Chao,L.
    Biochemistry, regulation and potential function of kallistatin
    Biol Chem Hoppe Seyler376, 705-713. PubMed  Europe PubMed
1993
24. [YEAR:15-11-1993]Chai,K.X., Chen,L.M., Chao,J. and Chao,L.
    Kallistatin: a novel human serine proteinase inhibitor. Molecular cloning, tissue distribution, and expression in Escherichia coli
    J Biol Chem268, 24498-24505. PubMed  Europe PubMed
1992
25. [YEAR:25-12-1992]Zhou,G.X., Chao,L. and Chao,J.
    Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence
    J Biol Chem267, 25873-25880. PubMed  Europe PubMed
1986
26. Chao,J., Tillman,D.M., Wang,M.Y., Margolius,H.S. and Chao,L.
    Identification of a new tissue-kallikrein-binding protein
    Biochem J239, 325-331. PubMed  Europe PubMed